OrganiGram Holdings Inc.

OrganiGram Holdings, Inc. engages in the production and sale of medical marijuana. It focuses on producing cannabis for patients and adult recreational consumers. The firm's brands include Adult Recreational and Medical. The company was founded on July 5, 2010 and is headquartered in Moncton, Canada.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

OrganiGram Holdings, Inc. engages in the provision of high-quality, indoor-grown cannabis for patients and adult recreational consumers and developing international business partnerships to extend the company’s global footprint. Its brands include Edison, Big Bag O’ Buds, SHRED, Monjour, and Trailblazer. The company was founded on July 5, 2010 and is headquartered in Toronto, Canada.

Novocure

Twitter

Berry Petroleum Corp.

Cardlytics

Global Blood Therapeutics

Synchrony Financial

Atlassian

YUM! Brands

With the trading day about halfway over, the broad markets were again somewhat mixed.

NovoCure, Synchrony, Twitter, Yum! and More Wednesday Afternoon Analyst Calls

Palantir Technologies

These futuristic stocks can yield solid returns in the coming years.

Have $1,000? Consider Buying These 2 Unstoppable Stocks

OrganiGram Holdings Inc. (OGI) CEO Greg Engel on Q2 2021 Results - Earnings Call Transcript

Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI) reported Tuesday that gross revenue decreased by 29% year-over-year to roughly CA$19.3 million ($15.4 million) in the second quarter of fiscal 2021. Net revenue also declined over the same period, from CA$23.2 million to CA$14.6 million, the Moncton, New Brunswick-based company said in a statement.

Organigram Reports Q2 Results: What Cannabis Stock Investors Need To Know

Investors initially reacted negatively to the Canadian cannabis company's quarterly results.

Why OrganiGram Holdings Stock Dropped Today

There were multiple culprits behind the cannabis producer's top- and bottom-line deterioration.

Why OrganiGram's Q2 Results Were So Ugly

OrganiGram (OGI) delivered earnings and revenue surprises of -200.00% and -26.82%, respectively, for the quarter ended February 2021. Do the numbers hold clues to what lies ahead for the stock?

OrganiGram (OGI) Reports Q2 Loss, Lags Revenue Estimates

OrganiGram Holdings Inc. said Tuesday it had a net loss of C$66.4 million ($52.8 million) in its fiscal second quarter to Feb. 28, wider than the loss of C$6.8 million posted in the year-earlier quarter. The Canadian cannabis company did not provide a per-share figure.

OrganiGram loss widens and revenue falls short of estimates in Q2 as COVID impacts staffing

MONCTON, New Brunswick--(BUSINESS WIRE)---- $OGI--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the second quarter ended February 28, 2021 (“Q2 2021”). “Although Q2 2021 results were challenged by industry dynamics, COVID-19 and staffing limitations at our facility, we believe there are excellent prospects ahead for the industry, Organigram and our shar

Organigram Reports Second Quarter Fiscal 2021 Results

Canopy Growth

Greenlane Holdings

HEXO Corp

FSD Pharma

Innovative Industrial Properties

Akerna Corp

SNDL Inc.

cbdMD Inc

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will continue to develop in the 2021.

These 9 Cannabis Stocks Caught Fire This Week

Organigram's acquisition of a Canadian edibles company gives it a step up in growing segment of cannabis. It's good news for OGI stock.

OrganiGram Looks Pretty Tastey as It Goes Big on Edibles

Aphria

AdvisorShares Pure US Cannabis ETF

Tilray Brands

The global pandemic and following lockdowns impacted almost every sector of the economy. And the Canadian cannabis industry was no exception.

Cannabis Analyst: March Earning Season May Not Push Canadian LPs, But There Are Other Catalysts

Fastenal

The next edition of earnings season begins in earnest next Wednesday morning, with three of the nation's biggest banks releasing fiscal first-quarter results before the opening bell is rung.

Earnings Previews: OrganiGram, Fastenal

Carvana

DocuSign

Bilibili

Bill.com

F5 Networks

Texas Roadhouse

With the trading day more than halfway over, the broad markets were somewhat mixed on the day.

Carvana, DocuSign, Organigram and More Thursday Afternoon Analyst Calls

British American Tobacco

Frontline

GW Pharmaceuticals

Jazz Pharmaceuticals

Amplify Alternative Harvest ETF

Nordic American Tankers

Star Bulk Carriers

Teekay Tankers

These 2 Stock Market Plays Are Moving Up the Charts in 2021

Recent developments bode well for OGI stock, but it needs the United States to legalize marijuana on a federal level for another big boost. The post After a Recent Run, OrganiGram Stock Could Hold Steady appeared first on InvestorPlace.

After a Recent Run, OrganiGram Stock Could Hold Steady

OrganiGram (OGI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

OrganiGram (OGI) Expected to Beat Earnings Estimates: Should You Buy?

OGI stock has taken a wild ride in 2021 so far. However, a major vote of confidence from a tobacco-market giant should sooth some investors.

As a Big Tobacco Firm Strikes a Major Deal, Hold On to Your OrganiGram Stock

Organigram Holdings Inc. said Tuesday it has acquired The Edibles & Infusions Corp. for C$22 million, plus up to an additional C$13 million in shares, in its first deal since receiving a C$221 million investment from British American Tobacco PLC.

Cannabis Watch: Organigram's first deal since securing $176 million investment from BAT will expand cannabis edibles line

Organigram Holdings Inc. (TSX:OGI) (NASDAQ:OGI) has purchased The Edibles & Infusions Corp. for $22 million. The Moncton, New Brunswick-bassed company agreed to acquire all of the issued and outstanding shares of the soft chew manufacturer co-founded by AgraFlora Organics International Inc. (OTC:AGRA) and Cavalier Candies CEO James Fletcher.

Organigram Acquires THC Soft Chew Manufacturer Edibles & Infusions In $22M Deal

With gains ranging from 139% to 175%, these pot stocks were all the buzz.

The 4 Best Marijuana Stocks in the First Quarter

Cronos Group

Coca-Cola

Altria

Philip Morris

There could be some big deals on the way.

This Surprising Projection Shows Why Big Tobacco Is Moving Into Cannabis

MONCTON, New Brunswick--(BUSINESS WIRE)---- $OGI--Organigram Holdings Inc. (“OGI”, TSX: OGI and NASDAQ: OGI), the parent company of Organigram Inc. (together with OGI, “Organigram” or the “Company”), a leading producer of cannabis, is pleased to announce it has acquired all of the issued and outstanding shares of The Edibles & Infusions Corporation (“EIC”) (the “EIC Acquisition”) for consideration of $22.0 million, plus up to an additional $13.0 million in shares (the “Milestone Consideration”) paya

Organigram Acquires Soft Chew Manufacturer: Edibles & Infusions Corporation, a Cannabis Processor Backed by Decades of Confectionary Experience

MONCTON, New Brunswick--(BUSINESS WIRE)---- $OGI--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its second quarter Fiscal 2021 ended February 28, 2021 on Tuesday April 13, 2021 before market open. The Company will host a conference call to discuss the results: Date: April 13, 2021 Time: 8:00 am Eastern Time To register for the conference

Organigram to Report Second Quarter Fiscal 2021 Results on April 13, 2021

The Canadian cannabis company got a boost from a new strategic partnership.

Why Organigram Holdings Jumped 14.5% in March

News for OrganiGram Holdings Inc. Stock (OGI)